(FRVIA) Forvia SE - Overview
Stock: Seats, Dashboards, Headlights, Exhausts, Displays
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 49.9% |
| Relative Tail Risk | -6.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 28.47 |
| Character TTM | |
|---|---|
| Beta | 0.364 |
| Beta Downside | 0.753 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.12% |
| CAGR/Max DD | -0.16 |
Description: FRVIA Forvia SE January 13, 2026
Forvia SE (FRVIA) is a global automotive technology supplier headquartered in Nanterre, France, operating across six core segments: Seating, Interiors, Clean Mobility, Electronics, Lighting, and Lifecycle Solutions. The company designs, manufactures and sells a broad portfolio ranging from vehicle seats and instrument panels to exhaust systems, driver-assistance electronics, lighting modules, and aftermarket workshop equipment.
Key recent metrics indicate a 2023 revenue of €23.2 billion, with the Seating and Clean Mobility segments together contributing roughly 55 % of sales. EBIT margin improved to 5.8 % YoY, driven by higher mix from electrified power-train components and cost-saving initiatives in the Electronics division.
Sector drivers that materially affect Forvia’s outlook include the accelerating shift to electric vehicles (EVs), which is expanding demand for lightweight seating, advanced cockpit electronics, and exhaust-aftertreatment alternatives; and the tightening of emissions regulations in Europe and China, pressuring commercial-vehicle manufacturers to adopt fuel-cell and zero-emission solutions-areas where Forvia’s Clean Mobility business is positioned to capture growth.
Assuming a modest 5 % CAGR in global EV sales through 2027 and a stable euro-dollar exchange rate, Forvia’s exposure to high-growth EV components could lift its revenue CAGR to 4–5 % over the next three years, though execution risk remains around supply-chain bottlenecks for semiconductors and raw materials.
For a deeper quantitative assessment, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -317.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 4.93 > 1.0 |
| NWC/Revenue: -0.79% < 20% (prev -0.61%; Δ -0.18% < -1%) |
| CFO/TA 0.15 > 3% & CFO 4.47b > Net Income -317.1m |
| Net Debt (6.48b) to EBITDA (3.48b): 1.86 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (196.5m) vs 12m ago -0.55% < -2% |
| Gross Margin: 13.42% > 18% (prev 0.13%; Δ 1329 % > 0.5%) |
| Asset Turnover: 136.2% > 50% (prev 134.1%; Δ 2.15% > 0%) |
| Interest Coverage Ratio: 1.46 > 6 (EBITDA TTM 3.48b / Interest Expense TTM 1.23b) |
Altman Z'' 0.61
| A: -0.01 (Total Current Assets 12.75b - Total Current Liabilities 13.07b) / Total Assets 28.95b |
| B: 0.05 (Retained Earnings 1.56b / Total Assets 28.95b) |
| C: 0.06 (EBIT TTM 1.79b / Avg Total Assets 29.72b) |
| D: 0.10 (Book Value of Equity 2.27b / Total Liabilities 23.55b) |
| Altman-Z'' Score: 0.61 = B |
Beneish M -3.29
| DSRI: 0.90 (Receivables 4.09b/4.56b, Revenue 40.48b/40.87b) |
| GMI: 0.97 (GM 13.42% / 12.97%) |
| AQI: 1.03 (AQ_t 0.38 / AQ_t-1 0.36) |
| SGI: 0.99 (Revenue 40.48b / 40.87b) |
| TATA: -0.17 (NI -317.1m - CFO 4.47b) / TA 28.95b) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of FRVIA shares?
Over the past week, the price has changed by +0.18%, over one month by -0.88%, over three months by +22.46% and over the past year by +41.08%.
Is FRVIA a buy, sell or hold?
What are the forecasts/targets for the FRVIA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.2 | 8.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 15 | 7.1% |
FRVIA Fundamental Data Overview February 03, 2026
P/E Forward = 2.4096
P/S = 0.0951
P/B = 0.7061
P/EG = 0.1065
Revenue TTM = 40.48b EUR
EBIT TTM = 1.79b EUR
EBITDA TTM = 3.48b EUR
Long Term Debt = 8.76b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.29b EUR (from shortTermDebt, last quarter)
Debt = 10.85b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.48b EUR (from netDebt column, last quarter)
Enterprise Value = 12.40b EUR (2.56b + Debt 10.85b - CCE 1.01b)
Interest Coverage Ratio = 1.46 (Ebit TTM 1.79b / Interest Expense TTM 1.23b)
EV/FCF = 4.87x (Enterprise Value 12.40b / FCF TTM 2.55b)
FCF Yield = 20.53% (FCF TTM 2.55b / Enterprise Value 12.40b)
FCF Margin = 6.29% (FCF TTM 2.55b / Revenue TTM 40.48b)
Net Margin = -0.78% (Net Income TTM -317.1m / Revenue TTM 40.48b)
Gross Margin = 13.42% ((Revenue TTM 40.48b - Cost of Revenue TTM 35.05b) / Revenue TTM)
Gross Margin QoQ = 13.69% (prev 13.29%)
Tobins Q-Ratio = 0.43 (Enterprise Value 12.40b / Total Assets 28.95b)
Interest Expense / Debt = 2.63% (Interest Expense 285.4m / Debt 10.85b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 1.35b (EBIT 1.79b * (1 - 25.00%))
Current Ratio = 0.98 (Total Current Assets 12.75b / Total Current Liabilities 13.07b)
Debt / Equity = 2.95 (Debt 10.85b / totalStockholderEquity, last quarter 3.67b)
Debt / EBITDA = 1.86 (Net Debt 6.48b / EBITDA 3.48b)
Debt / FCF = 2.55 (Net Debt 6.48b / FCF TTM 2.55b)
Total Stockholder Equity = 4.21b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.07% (Net Income -317.1m / Total Assets 28.95b)
RoE = -7.53% (Net Income TTM -317.1m / Total Stockholder Equity 4.21b)
RoCE = 13.83% (EBIT 1.79b / Capital Employed (Equity 4.21b + L.T.Debt 8.76b))
RoIC = 9.96% (NOPAT 1.35b / Invested Capital 13.52b)
WACC = 2.98% (E(2.56b)/V(13.41b) * Re(7.26%) + D(10.85b)/V(13.41b) * Rd(2.63%) * (1-Tc(0.25)))
Discount Rate = 7.26% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.27%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈2.00b ; Y1≈2.46b ; Y5≈4.20b
Fair Price DCF = 624.5 (EV 122.23b - Net Debt 6.48b = Equity 115.76b / Shares 185.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 31.61 | EPS CAGR: 21.54% | SUE: 0.0 | # QB: 0
Revenue Correlation: 52.88 | Revenue CAGR: 15.77% | SUE: -0.01 | # QB: 0
EPS next Year (2026-12-31): EPS=1.98 | Chg30d=+0.039 | Revisions Net=+0 | Growth EPS=+208.8% | Growth Revenue=+0.3%